In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy

Annals of Neurology

Volumn 42, Issue 4, 1997, Pages 573-579

  Lodi, R ^a   Taylor, D J ^a   Tabrizi, S J ^b   Kumar, S ^a   Sweeney, M ^c   Wood, N W ^c   Styles, P ^a   Radda, G K ^a   Schapira, A H V ^b,c  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; PHOSPHORUS 31;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEREDITARY OPTIC ATROPHY; HETEROZYGOTE; HUMAN; IN VIVO STUDY; MALE; MITOCHONDRION; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; AGED; DNA, MITOCHONDRIAL; ENERGY METABOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MUTATION; OPTIC ATROPHIES, HEREDITARY; PHOSPHORUS RADIOISOTOPES;

EID: 0030881830     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420407     Document Type: Article

References (37)

1. Riordan-Eva P, Harding AE. Leber's hereditary optic neuropathy, the clinical relevance of different mitochondrial DNA mutations. J Med Genet 1995;32:81-87
2. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430
3. Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet 1992;51: 1218-1228.
4. Johns DR, Heher KL, Miller NR, Smith KM. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993;111:495-498
5. Howell N, Bindoff LA, McCullough DA, et al. Leber's hereditary optic neuropathy, identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49: 939-950
6. Huoponen K, Vilkki J, Aula P, et al. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991;48:1147-1153
7. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995;57: 77-86
8. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118:319-337
9. Howell N. Primary LHON mutations: trying to separate truit from "chaf." Clin Neurosci 1994;2:130-137
10. Majander A, Huoponen K, Savontaus M-L, et al. Electron transfer properties of NADH: ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett 1991;292: 289-292
11. Larsson N-G, Andersen O, Holme E, et al. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991;30:701-708
12. Cortelli P, Montagna P, Avoni P, et al. Leber's hereditary optic neuropathy: genetic, biochemical and phosphorus magnetic resonance spectroscopy study in an Italian family. Neurology 1991;41:1211-1215
13. Smith PR, Cooper JM, Govan GG, et al. Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 1994;122:80-83
14. Vergani L, Martinuzzi A, Carelli V, et al. MtDNA mutations associated with Leber's hereditary optic neuropathy: studies on cytoplasmic hybrid (cybrid) cells. Biochem Biophys Res Commun 1995;210:880-888
15. Oostra R-J, VanGalen MJM, Bolhuis PA, et al. The mitochondrial DNA mutation ND6*14,484C associated with Leber hereditary optic neuropathy, leads to deficiency of complex I of the respiratory chain. Biochem Biophys Res Commun 1995; 215:1001-1005
16. Cock HR, Cooper JM, Schapira AHV. The 14484 ND6 mtDNA mutation in Leber hereditary optic neuropathy does not affect fibroblast complex I activity. Am J Hum Genet 1995; 57:1501-1502
17. 31P magnetic resonance spectroscopy in non-affected carriers of 11778 mtDNA mutation. Neurology 1995;45:1364-1369
18. Radda GK. Control of energy metabolism during muscle contraction. Diabetes 1995;45(suppl 1):88-92
19. Matthews PM, Allaire C, Shoubridge EA, et al. In vivo muscle magnetic resonance spectroscopy in the clinical investigation or mitochondrial disease. Neurology 1991;41:114-120
20. 31P-magnetic resonance spectroscopy in NARP syndrome. J Neurol Neurosurg Psychiatry 1994; 57:1492-1496
21. Sweeney M, Davis M, Lashwood A, et al. Evidence against an X-linked locus closed to DXS7 determining visual loss susceptibility in British and Italian families with Leber's hereditary optic neuropathy. Am J Hum Genet 1992;51:741-748
22. Durnin J, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness; measurements in 481 man and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97
23. Arnold DL, Taylor DJ, Radda GK. Investigations of human mitochondrial myopathies by phosphorous magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196
24. Veech RL, Lawson JWR, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem 1979;254:6538-6547
25. Kemp GJ, Taylor DJ, Radda GK. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle. NMR Biomed 1993;6:66-72
26. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J Biol Chem 1955;217: 409-427
27. Howell N, Xu M, Halvorson S, et al. A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation. Am J Hum Genet 1994;55:203-206
28. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31: 391-398
29. (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 1992;51:1201-1212
30. (8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF): relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993;116:617-632
31. 31phosphorus NMR. J Biol Chem 1985;260:3947-3954
32. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR. Magn Reson Med 1984;1:307-315
33. Taylor DJ, Bore PJ, Gadian DG, Radda GK. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med 1983;1:77-94
34. 31P MRS of abnormal mitochondrial oxidative in skeletal muscle during recovery from exercise. NMR Biomed 1993; 6:302-310
35. Taylor DJ, Kemp GJ, Radda GK. Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci 1994;127:198-206
36. Taylor DJ, Kemp GJ, Woods CG, et al. Skeletal muscle bioenergetics in myotonic dystrophy. J Neurol Sci 1993;116:193-200
37. Johns DR, Smith KH, Miller NR. Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol 1992;110:1577-1581